Prashant Kumar

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Genes, chromosomes & cancer

JCO precision oncology

Medical oncology (Northwood, London, England)

Cancers

Institute of Bioinformatics

Max Planck Institute for Infection Biology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Bioinformatics

India

Faculty Scientist

Education History

Max Planck Institute for Infection Biology

Germany

PHD

University of Allahabad

India

MSC

Publications

Prerana Jha, Ruma Pengal, Minit Shah, Pooja Mahesh Kulkarni, Rohit Mishra, Nandini Menon, Narendranath Vikkath, Santosh Menon, Venkataramanan Ramachandran, Gagan Prakash, Vanita Noronha, Kumar Prabhash, Prashant Kumar
Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma. Genes, chromosomes & cancer 63 (6) (2024)
Prerana Jha, Ruma Pengal, Minit Shah, Pooja Mahesh Kulkarni, Rohit Mishra, Nandini Menon, Narendranath Vikkath, Santosh Menon, Venkataramanan Ramachandran, Gagan Prakash, Vanita Noronha, Kumar Prabhash, Prashant Kumar
Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma. Genes, chromosomes & cancer 63 (6) (2024)
Sewanti A Limaye, Prashant Kumar, Rajan Datar, Aditya Shreenivas
Reply to S. Cavalieri et al. JCO precision oncology 5 (2022)
Ajay Balakrishnan, Antony George Francis Thottian, K Govind Babu, Prashant Kumar
Drug susceptibility testing of circulating lung cancer cells for personalized treatment. Medical oncology (Northwood, London, England) 40 (1) (2022)
Ankit P Jain, Janani Sambath, Gajanan Sathe, Irene A George, Akhilesh Pandey, Erik W Thompson, Prashant Kumar
Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach. Journal of translational medicine 20 (1) (2022)
Kirti Gondkar, Gajanan Sathe, Neha Joshi, Bipin Nair, Akhilesh Pandey, Prashant Kumar
Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer. Cells 10 (3) (2021)
Rui Miguel Marques Bernardino, Ricardo Romão Nazário Leão, Rui M Henrique, Luis Campos Pinheiro, Prashant Kumar, Prashanth Suravajhala, Hans Christian Beck, Ana Sofia Carvalho, Rune Matthiesen
Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies. International journal of molecular sciences 22 (24) (2021)
Vinuth N Puttamallesh, Barnali Deb, Kirti Gondkar, Ankit P Jain, Bipin Nair, Akhilesh Pandey, Aditi Chatterjee, Harsha Gowda, Prashant Kumar
Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target. Genes 11 (7) (2020)
Ana Sofia Carvalho, Maria Carolina Strano Moraes, Chan Hyun Na, Ivo Fierro-Monti, Andreia F A Henriques, Sara Zahedi, Cristian Bodo, Erin M Tranfield, Ana Laura Sousa, Ana Farinho, Luis Vaz Rodrigues, Paula Pinto, Cristina Bárbara, Leonor Mota, Tiago Tavares de Abreu, Júlio Semedo, Susana Seixas, Prashant Kumar, Bruno Costa Silva, Akhilesh Pandey, Rune Matthiesen
Is the Proteome of Bronchoalveolar Lavage Extracellular Vesicles a Marker of Advanced Lung Cancer? Cancers 12 (11) (2020)

Prashant Kumar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Prashant Kumar